Company profile: LGC
1.1 - Company Overview
Company description
- Provider of life sciences measurement and testing solutions, delivering reference materials, genomics and agbio solutions, clinical and molecular diagnostics, analytical testing, and food and water safety testing, plus government partnership services for evidence-based decision-making, supported by expertise in regulation, accreditation, and standard setting.
Products and services
- Reference Materials: Standards-led components delivering assurance across transportation and industrial manufacturing by verifying production processes meet environmental and security requirements
- Genomics Solutions: Accreditation-backed tools engineered to enhance agricultural yield, food quality, and disease tolerance through genomics for targeted improvements in farming outcomes
- Clinical and Molecular Diagnostics: Regulation-grounded diagnostics developed to deliver more accurate clinical outcomes and enable innovative health treatments across healthcare applications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to LGC
Pairwise
HQ: United States
Website
- Description: Provider of plant-based innovation via the Fulcrum platform to accelerate production systems, developing seedless blackberries, black raspberries, red raspberries, and pitless cherries with year-round availability, and offering the Good Food for All program to expand access to fruits and vegetables.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pairwise company profile →
PlasmidFactory
HQ: Germany
Website
- Description: Provider of contract manufacturing for plasmid and minicircle DNA, serving cancer research, gene and cell therapy, CAR T-cell development, and vaccination. Offerings include plasmid DNA production, minicircle DNA vectors, capillary gel electrophoresis quality control, GMP-compliant long-term DNA storage, and R&D services in plasmid and minicircle DNA technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PlasmidFactory company profile →
Epistem
HQ: United Kingdom
Website
- Description: Provider of specialist contract research services supporting drug discovery and development, offering preclinical in vitro/in vivo models in oncology, inflammatory and gastrointestinal diseases (incl. GI toxicities); GCLP-accredited clinical trial support (histology, IHC, image analysis, gene expression, DNA genotyping); organoid models; cancer stem cell sphere assays; subcutaneous xenografts; orthotopic/metastatic bioluminescent models.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Epistem company profile →
Gentris
HQ: United States
Website
- Description: Provider of global pharmacogenomic testing and biorepository services, helping pharmaceutical companies and clinical research organizations integrate pharmacogenomics into drug development to deliver safer, more effective compounds to market more quickly.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gentris company profile →
Onkaido Therapeutics
HQ: United States
Website
- Description: Provider of research into messenger RNA therapeutics aimed at delivering novel oncology drugs to help patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Onkaido Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for LGC
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to LGC
2.2 - Growth funds investing in similar companies to LGC
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for LGC
4.2 - Public trading comparable groups for LGC
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →